- Home
- COF vs PFE Comparison
COF vs PFE Comparison
Compare COF & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COF | PFE |
|---|---|---|
| Founded | 1988 | 1849 |
| Country | United States | United States |
| Employees | 77100 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.4B | 147.6B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | COF | PFE |
|---|---|---|
| Price | $200.18 | $26.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $258.94 | $29.29 |
| AVG Volume (30 Days) | 4.6M | ★ 25.7M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | 1.68% | ★ 6.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $62,579,000,000.00 |
| Revenue This Year | $95.92 | N/A |
| Revenue Next Year | $4.90 | N/A |
| P/E Ratio | ★ $52.03 | $55.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $174.24 | $23.11 |
| 52 Week High | $259.64 | $28.75 |
Technical Indicators
Market Signals| Indicator | COF | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 65.85 | 49.50 |
| Support Level | $199.85 | $25.06 |
| Resistance Level | $210.92 | $25.99 |
| Average True Range (ATR) | 5.38 | 0.41 |
| MACD | 1.83 | 0.07 |
| Stochastic Oscillator | 97.77 | 56.15 |
Price Performance
Historical ComparisonAbout COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending provides the majority of the bank's revenue.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.